Holen Sie sich die Stockscreener-App
357.65
0.57%
-2.05
Handel nachbörslich:
357.65
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services (WST) Enters Strategic Agreements w - GuruFocus
West Pharmaceutical (NYSE: WST) inks 10-year Daikyo licensing, distribution deal - Stock Titan
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry - Yahoo Finance
3 Reasons WST is Risky and 1 Stock to Buy Instead - Yahoo Finance
BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target - Moomoo
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $383.93, Implies 9% Upside - TradingView
West Synchrony Prefillable Syringe System Available at CPHI Southeast Asia - BioSpectrum Asia
WST completes SmartDose sale to AbbVie to focus on core growth - MSN
West Pharmaceutical stock holds steady as drug-delivery leader builds on long-term growth story - Ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business - Yahoo Finance
Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care - TradingView
West Pharmaceutical stock reflects steady demand for drug delivery components - Ad-hoc-news.de
The Bull Case For West Pharmaceutical Services (WST) Could Change Following Its Q1 2026 Earnings Beat And UpgradesLearn Why - Sahm
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharma Price Target Raised to $365.00/Share From $325.00 by Morgan Stanley - Moomoo
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - TradingView
Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 - marketscreener.com
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $370.23, Implies 5% Upside - TradingView
WST Completes SmartDose Sale to AbbVie to Focus on Core Growth - Yahoo Finance
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Raises Target Price to $365 - Moomoo
West Pharmaceutical outlines long-term growth drivers as investors track U.S. healthcare demand - ad-hoc-news.de
West Launches Synchrony™ Prefillable Syringe System for Biologics and Vaccines in Southeast Asia - BioPharma APAC
WST stock up nearly 33% YTD: Will the uptrend continue in the rest of 2026? - MSN
The Daikyo D2F Series PlungerWest Pharmaceutical focuses on high-barrier safety for prefilled syr - Ad-hoc-news.de
West Pharmaceutical Services (WST) Is Up 4.24% in One Week: What You Should Know - Yahoo Finance
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - TradingView
West to Host Second-Quarter 2026 Conference Call - BioSpace
WST Maintains Rating by Evercore ISI Group -- Price Target Raises to $410 - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical updates strategy as global demand for drug delivery grows - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings - Yahoo Finance
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? L - The National Law Review
West Pharmaceutical Services Stock 10-Day Winning Spree: Stock Climbs 13% - Trefis
West Pharmaceutical rises on upbeat results, guidance raise - MSN
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - TradingView
West completes sale of on-body drug delivery device to AbbVie - Drug Delivery Business
West Pharmaceutical Services Stock Rockets 13% With 9-Day Winning Streak - Trefis
What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report - Yahoo Finance
KeyBanc Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $390 - Moomoo
West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Growth on Drug Delivery Demand - Sahm
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System - Sahm
KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services stock hits 52-week high at 363.38 USD - Investing.com India
West Pharmaceutical completes sale of SmartDose 3.5mL system By Investing.com - Investing.com Australia
Form 4 West Pharmaceutical Services Inc For: 1 July By Investing.com - Investing.com Canada
West Pharmaceutical (WST) director awarded new phantom stock units and RSUs - Stock Titan
West Pharmaceutical completes sale of SmartDose 3.5mL system - Investing.com
Westar™ RS LyoVials from West Pharmaceuticalmodular containment for complex injectables - AD HOC NEWS
West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable DemandHas The Bull Case Changed? - Yahoo Finance
West Pharmaceutical Services, Inc.'s stock price skyrockets to $359.00, boasting a promising 1.22% increase - Smartkarma
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView
WST Technical Analysis & Stock Price Forecast - Intellectia AI
The SmartDose Gen. II injector from West Pharmaceutical Services Inc.wearable biologics delivery - AD HOC NEWS
West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch
2.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):